This inventor holds 1 USPTO granted patent. Top assignee: Daiamed, Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Scott R. Magee: Innovator in Thrombosis Treatment
Introduction
Scott R. Magee is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of thrombosis. His innovative work focuses on developing compounds that can inhibit Factor XIa, a key player in the blood clotting process.
Latest Patents
Scott R. Magee holds one patent titled "Compounds and methods for treatment of thrombosis." This invention provides compounds that inhibit Factor XIa and outlines methods for preventing or treating undesired thrombosis by administering these compounds to mammals. Additionally, the patent includes three-dimensional structures of Factor XIa, which can be utilized for designing or selecting further Factor XIa inhibitors.
Career Highlights
Scott is associated with Daiamed, Inc., where he applies his expertise in developing innovative medical solutions. His work has the potential to significantly impact the treatment of thrombotic conditions, improving patient outcomes.
Collaborations
Scott has collaborated with talented individuals such as Sherin Salaheldin Abdel-Meguid and Robert Edward Babine. These partnerships enhance the research and development efforts at Daiamed, Inc.
Conclusion
Scott R. Magee is a dedicated inventor whose work in thrombosis treatment showcases the importance of innovation in medicine. His contributions are paving the way for new therapeutic approaches that could benefit many patients.